Company
PRIVATE:[TICKER]
Pan-Biome Pharmaceuticals Inc is a preclinical biopharmaceutical company with a suite of natural product-based compounds dedicated to healthy aging and advancing drugs that can treat and potentially slow the onset of many age-related diseases. Its compounds are well tolerated and exhibit novel anti-inflammatory, antimicrobial, antioxidant, and anti-cancer properties. In July 2020, the private company was spun out from Derm-Biome Pharmaceuticals Inc, a Vancouver-based pre-clinical biopharma company focused on skin diseases and healthy ageing.
223 stories · page 11 of 12
The company said it intends to use the proceeds from the private placement to fund acquisitions, as working capital purposes and for fees associated with the listing of its shares
Archive
Before the news broke on Tesla and Bitcoin, we were planning a research note on Ark Invest holdings across their five actively managed ETFs. Our motivation was driven by the fact that Ark Invest recently pushed above $50bn in asset under ma
The funds will support platform automation and team growth as MPOWER finances thousands of additional international and DACA students at over 350 universities across North America
The proceeds will be used to boost the current offering and support restaurants and riders
The takeaway delivery app is reportedly planning a float in April this year that could see it reach a value of as much as £8bn
Archive
Arc Minerals* (LON:ARCM) – Arc Minerals extends exclusivity agreement with Anglo for a further 180 days Cornish Metals* (CVE:CUSN) – Intention to float on AIM market Greatland Gold (LON:GGP) – Newcrest approves A4146m for preparatory mining
The firm also launched its Candidate Selection program, which will zero in on the molecules that MagicMed believes have the best characteristics to become pharmaceutical drugs
Archive
The UK's top share index closed up over 57 points at 6,570, while midcap FTSE 250 added over 244 points at 20,096
The company also said it will increase its previously-announced private placement financing to C$4.5 million due to increased demand
Archive
The Chancellor of the Exchequer is facing an uphill battle as he attempts to find funding both for the government's policy agenda as well as to repair the gaping hole left in the Treasury by the pandemic
MagicMed said it will be able to leverage state-of-the-art equipment and laboratory space and draw upon the institution’s “world class” expertise
Archive
Oil price Genel Energy (LON:GENL) Genel has announced that DNO as operator has announced an update on the Tawke PSC licence activity.
Archive
House Speaker Nancy Pelosi and Treasury Secretary Steven Mnuchin held an hourlong phone call Monday
The team is using this cash injection to “expedite and amplify” development of the MagicMed Psybrary
The funds will help expand MagicMed’s Psybrary, a molecular derivatives library designed to be a key platform for the psychedelics industry to develop new patented products
Archive
Oil drifted yesterday as per my comments in the late blog, so many conference calls! Hurricane Laura has moved on and is now a lowly Tropical Storm but has left a good deal of wreckage in its wake. Oil will get back to normal soon, crude pr
Archive
Hurricane Laura has arrived onshore on the Texas/Louisiana border but has already been downgraded from a category 4 to a 3 so whilst it still maybe ‘unsurvivable’ it appears to be weakening. Having said that it will have already had an effe
Archive
Amur Minerals* (LON:AMC) - £6.1m equity raise and Australian iron ore project investment Condor Gold* (LON:CNR) – Click here for Initiation note pdf – Director adds to his shareholding Eurasia Mining *(LON:EUA) – Approval for licenses for M
MagicMed’s Psybrary is a molecular derivatives library designed to be a key platform for the psychedelics industry to develop new patented products
The company expects the filing to be the first in a series of applications that together are designed to protect its portfolio of novel derivatives known as the Psybrary
